CriticalProkinetic, peripheral dopamine D2 receptor antagonist×Antifungal, triazole
Updated · Methodology
Mechanism
CYP3A4 is the main enzyme that metabolises domperidone, and itraconazole strongly inhibits it (domperidone and itraconazole summaries of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). With itraconazole, the peak concentration after a 20 mg domperidone dose rose 2.7-fold and the area under the concentration curve (AUC) 3.2-fold (itraconazole SmPC, AEMPS). Domperidone has been associated with QT prolongation, serious ventricular arrhythmias and sudden cardiac death. The risk is higher in people who also take drugs that prolong QT or CYP3A4 inhibitors (domperidone SmPC, AEMPS). Itraconazole is contraindicated with a list of CYP3A4 substrates because their high levels can prolong QT and cause ventricular tachyarrhythmias, including life-threatening torsade de pointes (itraconazole SmPC, AEMPS).
Symptoms
QT prolongation itself causes no symptoms and shows only on the electrocardiogram (ECG). Ventricular arrhythmias cause palpitations, dizziness and fainting. Prolongation of the corrected QT interval, ventricular arrhythmias, torsade de pointes and sudden cardiac death have been reported with domperidone (domperidone summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). Domperidone overdose can cause agitation, altered consciousness, disorientation, drowsiness, seizures and extrapyramidal reactions such as involuntary movements and muscle stiffness (domperidone SmPC, AEMPS).
Management
The combination is contraindicated in the labels of both drugs. The domperidone summary of product characteristics (SmPC) contraindicates strong inhibitors of the enzyme CYP3A4 and names itraconazole among them (domperidone SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). The SmPCs of the original itraconazole product and its generics list domperidone among contraindicated drugs (itraconazole SmPCs, AEMPS). Do not give domperidone during itraconazole treatment or for two weeks after it ends (itraconazole SmPC, AEMPS). After the last dose, itraconazole levels fall to almost undetectable in 7–14 days, and even more slowly in liver cirrhosis or with other CYP3A4 inhibitors (itraconazole SmPC, AEMPS). Stop domperidone if signs of arrhythmia appear (domperidone SmPC, AEMPS). In domperidone overdose, give supportive treatment and monitor the electrocardiogram (ECG), because the corrected QT interval (QTc) may lengthen (domperidone SmPC, AEMPS).
Your whole list in one report
Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email
Add more drugsMedicine list: everything you take in one place →
Sources
- AEMPS: Ficha técnica: Itraconazol (nº registro 59343), sección 4.3 (2025)– AEMPS, CIMA, nº registro 59343 (Sporanox 100 mg cápsulas), revisión 07/2025, secciones 4.3, 4.4 y 4.5
- AEMPS: Ficha técnica: Domperidona (nº registro 55411), sección 4.3 (2025)– AEMPS, CIMA, nº registro 55411 (Motilium 1 mg/ml suspensión oral, Esteve), revisión 09/2025, secciones 4.2, 4.3, 4.4 y 4.5